{"id":"W2593211227","doi":"10.1016/j.jaad.2016.12.014","title":"Clinical similarity of biosimilar ABP 501 to adalimumab in the treatment of patients with moderate to severe plaque psoriasis: A randomized, double-blind, multicenter, phase III study","year":2017,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":137,"is_retracted":false,"has_abstract":true,"ca_institutions":"SKiN Health; Probity Medical Research","funders":"","keywords":"Adalimumab; Medicine; Psoriasis Area and Severity Index; Clinical endpoint; Confidence interval; Psoriasis; Internal medicine; Adverse effect; Randomized controlled trial; Biosimilar; Surgery; Dermatology; Disease","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001375459,0.0002848204,0.00252496,0.0002215909,0.0001461942,0.00001214561,0.001303231,0.0002309279,0.00001754833],"category_scores_gemma":[0.00036274,0.0001339234,0.0005131642,0.0002318917,0.001448872,0.00008506719,0.0001722741,0.0005996484,0.000001327207],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003758103,"about_ca_system_score_gemma":0.00008609068,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001254281,"about_ca_topic_score_gemma":0.00004570865,"domain_scores_codex":[0.9948334,0.002441415,0.001925932,0.0002759869,0.0001810358,0.0003423073],"domain_scores_gemma":[0.9949577,0.001003745,0.003239682,0.0005149355,0.0002046547,0.00007923777],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8605986,0.01031948,0.1171276,0.00002543607,0.002429771,0.00001818527,0.001793903,0.00003661099,0.0005795819,0.00004404079,0.0005922294,0.006434632],"study_design_scores_gemma":[0.8825285,0.01081805,0.07451525,0.0002109509,0.002170638,0.0002057251,0.001977622,0.00005117786,0.02509986,0.0001551788,0.001918876,0.0003481541],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9836332,0.0002193417,0.000119476,0.01391882,0.0002278988,0.001790365,0.00006301297,0.000002696045,0.00002523595],"genre_scores_gemma":[0.9972253,0.0002782112,0.001116152,0.001297336,0.00002759495,0.00002773987,0.000001050088,0.00001283089,0.00001376202],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0426123,"threshold_uncertainty_score":0.5461239,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05762649998465511,"score_gpt":0.4055974419265284,"score_spread":0.3479709419418732,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}